<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">IMIQUIMOD</span><br/>(i-mi'qui-mod)<br/><span class="topboxtradename">Aldara<br/></span><b>Classifications:</b> <span class="classification">skin &amp; mucous membrane agent</span>; <span class="classification">keratolytic agent</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5% cream in 250 mg single use packets</p>
<h1><a name="action">Actions</a></h1>
<p>An "immune response modifier"; exact mechanism of action is unknown. Induces cytokine production, including interferon-alfa,
         which may interfere with viral replication.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Does not totally eradicate HPV. Despite destruction of HPV warts, latent or subclinical HPV infection can persist, and recurrence
         of visible warts is common.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of external genital and perianal warts <i>(Condylomata acuminate),</i> actinic keratosis on the face and scalp of immunocompetent adults, and superficial basal cell carcinoma.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Treatment of common warts.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Occlusive dressing; ocular exposure; excessive sun exposure or sunburn; UV exposure; surgery or drug treatment on affected
         area; pregnancy (category C); children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypersensitivity to benzyl alcohol or paraben; HIV infection; lactation</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Genital and Perianal Warts</span><br/><span class="rdage">Adult/Adolescent:</span> <span class="rdroute">Topical</span> &gt;<i>12 y</i> Apply a thin layer to the affected areas once daily 3 times per week just before bedtime. Wash off cream after 610
               h (max: 16 wk therapy).<br/><br/><span class="indicationtitle">Actinic Keratosis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply a thin layer to the affected areas once daily 2 times per week just before sleep for 16 wks. Wash off cream after 8
               h.<br/><br/><span class="indicationtitle">Superficial Basal Cell Carcinoma</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply a thin layer to the affected areas once daily 5  times per week just before sleep for 6 wk. Wash off cream after 8 h.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Hand washing before and after application is recommended.</li>
<li>Wash treatment area with soap and water and allow to dry thoroughly (at least 10 min).</li>
<li>Single-use packets contain sufficient cream to cover an area of up to 20 cm<sup>2</sup> (approx. 8 in. by 8 in.).
         </li>
<li>Instruct patient to apply a thin layer of cream (avoid using excessive cream), and work into area until no longer visible.
            Do not occlude the application site.
         </li>
<li>After each treatment period, remove the cream by washing the treated area with soap and water.</li>
<li>Store below 25° C (77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Fungal infections, flu-like symptoms, myalgia. <span class="typehead"> CNS:</span> Headache. <span class="typehead">Skin:</span>
<span class="speceff-common">Application site reactions, pruritus</span>
<i>,</i> burning, bleeding, stinging, redness, tenderness, irritation, <span class="speceff-common">erythema,</span>
<b> </b>edema, weeping/exudates, dry skin, scabbing/crusting, hyperkeratosis.<b></b>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  None reported. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Minimal absorption through intact skin. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Uncircumcised males with warts under the foreskin: Pull back the foreskin and clean the area daily to help avoid penile skin
            reactions.
         </li>
<li>Females should not apply cream directly into the vagina. Application to the labia may cause pain or swelling and may cause
            difficulty in passing urine.
         </li>
<li>Avoid or minimize UV light exposure (artificial and sunlight) during treatment of actinic keratosis. Wear protective clothing.
            If sunburn develops, avoid using imiquimod cream until fully recovered.
         </li>
<li>Do not breast feed without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>